المؤلفون: Van Hove, Johan LK, Friederich, Marisa W, Hock, Daniella H, Stroud, David A, Caruana, Nikeisha, Christians, Uwe, Schniedewind, Björn, Michel, Cole R, Reisdorph, Richard, Lopez Gonzalez, Edwin DJ, Brenner, Charles, Donovan, Tonia E, Lee, Jessica C, Chatfield, Kathryn C, Larson, Austin A, Baker, Peter Russell, McCandless, Shawn E, Moore Burk, Meghan F

مصطلحات موضوعية: 3201 Cardiovascular medicine and haematology, 3214 Pharmacology and pharmaceutical sciences, Institute for Health and Sport, cardiomyopathy, cardiac failure, mitochondrial disorder, bezafibrate, nicotinamide riboside, pharmacokinetic

Relation: https://vuir.vu.edu.au/48793/; https://doi.org/10.1016/j.mito.2024.101905; Van Hove, Johan LK, Friederich, Marisa W, Hock, Daniella H orcid:0000-0002-6940-4420 , Stroud, David A orcid:0000-0002-2048-3383 , Caruana, Nikeisha orcid:0000-0002-0817-1686 , Christians, Uwe orcid:0000-0001-7297-147X , Schniedewind, Björn, Michel, Cole R, Reisdorph, Richard orcid:0000-0003-3162-0571 , Lopez Gonzalez, Edwin DJ, Brenner, Charles orcid:0000-0002-4955-3226 , Donovan, Tonia E, Lee, Jessica C, Chatfield, Kathryn C, Larson, Austin A, Baker, Peter Russell, McCandless, Shawn E orcid:0000-0001-5719-1520 and Moore Burk, Meghan F (2024) ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis. Mitochondrion, 78. ISSN 1567-7249

الاتاحة: https://vuir.vu.edu.au/48793/
https://doi.org/10.1016/j.mito.2024.101905